Sorafenib plus octreotide is an effective and safe treatment in advanced hepatocellular carcinoma : multicenter phase II So.LAR. study

• PRETE SD

収録刊行物

• Cancer Chemother Pharmacol

  Cancer Chemother Pharmacol 66 837-844, 2010

詳細情報

• CRID: 1573950401142312576
• NII論文ID: 20000840717
• データソース種別:
  • CiNii Articles